The average sales price for two of Pfizer's biosimilars are falling far below those of competitors.

The big topics for discussion at AMCP Nexus 2026 included PBM reform, new drug pricing models, and artificial intelligence.

A new ICER report suggests much work remains to be done when it comes to the launch prices of novel medicines.

The second annual analysis examines launch prices and patient access for new FDA-approved treatments.

ICER based its net pricing data on estimates from three data sources, including IPD Analytics.

Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined Prime Therapeutics' Specialty Summit.

Andrew Levitsky, PharmD, BCPS, and Irvin Molina, PharmD, BCOP, BCPS, CSP, joined the AMCP Florida-Puerto Rico Day of Education.

Marina Sehman, PharmD, CSP, Director of Clinical Pharmacy at IPD Analytics, joined the AMCP California Day of Education.

Charles Haisch and Scott Allen presented at the Pharma and Biotech Patent Litigation Summit North America.

Part D enrollment has shifted: standalone plan offerings are down 22%, while special needs plans grew 21%, reshaping competition among fewer, larger sponsors nationally, finds an analysis by IPD Analytics.

Bethany Holderread, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education.

Jennifer Billings, Senior Director of Clinical Pharmacy at IPD Analytics, presented at the AMCP Great Plains Day of Education (DOE).

Alyssa Guest, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Bridging Regions, Aligning Stakeholders: Advancing Coordinated Care in Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)."

Bethany Holderread will present two sessions at the 2026 AMPAA Annual Conference.

Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented at the 2026 Texas Pharmacy Association Conference & Expo.

Some of the most widely prescribed and profit‑generating biologic therapies are set to lose exclusivity over the next few years, yet only a fraction have a biosimilar competitor currently in development.

Sheetal Sheth, PharmD, BCOP, presented "Rends in Commercial Payer Coverage of Accelerated Approval Therapies" poster on behalf of her co-authors Michelle Rogers, PharmD, BCPS, and Irvin Molina, PharmD, BCOP, BCPS, CSP, at Oncology Pharmacists Connect 2026.

Bethany Holderread, PharmD, Associate Director of Clinical Pharmacy at IPD Analytics, presented, "Most Favored Nation: A Closer Look Below the Surface" at the Mississippi Association of Health Plans Annual Conference.

Jeffrey Casberg, MS, RPh, Executive Vice President of Clinical Pharmacy at IPD Analytics, joined the AMCP Northeast Evening of Education panel on May 14, 2026.

Kimberly Grant, Director of Clinical Pharmacy at IPD Analytics, presented at AMCP Northwest Day of Education.

By FirstWord Pharma | Original Article BOSTON, May 4, 2026 - The Institute for Clinical and Economic Review (ICER) posted a Protocol today outlining how it will conduct its second annual analysis titled the “Launch Price and Access Report,” which will examine launch prices and patient access for new FDA-approved treatments. This protocol was developed with input from a multi-stakeholder working group* consisting of patient and consumer advocates, clinicians, policy experts, p

Jeffrey Casberg, MS, RPh, Senior Vice President of Clinical Pharmacy, and Julie Kendle, PharmD, Senior Director of Clinical Pharmacy at IPD Analytics, presented "Pharmaceutical Pipeline Update: What Employers Need to Know" at the Employers Health webinar.

Julie Kendle, Pharm.D., Senior Director of Clinical Pharmacy at IPD Analytics, explains how managed care organizations can support patients at risk of HIV.

Julie Kendle, Senior Director of Clinical Pharmacy at IPD Analytics, explains where managed healthcare organizations should look if they want to improve PrEP access and align with public health goals.